Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T01:01:05.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice about NIH terminology and website updates appears above the page, and the displayed site revision changes to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:54:24.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:00:52.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, blocking access to the content. The surrounding header/footer with a Home link suggests an access issue rather than a deliberate update to study details.
    Difference
    19%
    Check dated 2026-09-23T01:04:55.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    - The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new version of the study record was published. This reflects an update to the page metadata rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-09-16T00:07:13.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page shows a new revision label of v3.6.6, replacing v3.6.5. This indicates a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-09-01T19:47:35.000Z thumbnail image

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.